Effects of CP-060S, a novel Ca 2+ channel blocker, on oxidative stress in cultured cardiac myocytes

By Hara A.   Suzuki T.   Hashizume H.   Shishido N.   Nakamura M.   Ushikubi F.   Abiko Y.  

European Journal of Pharmacology, Vol. 385, Iss. 1, 1999-11 ,pp. : 81-88

Elsevier

Access to resources Recommend Favorite

Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca 2+ channels

By Kanda S.   Adachi-Akahane S.   Nagao T.  

European Journal of Pharmacology, Vol. 358, Iss. 3, 1998-10 ,pp. : 277-287

Elsevier

Access to resources Recommend Favorite

The binding interactions of Ro 40-5967 at the L-type Ca 2+ channel in cardiac tissue

By Rutledge A.   Triggle D.J.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite

Effects of anandamide and arachidonic acid on specific binding of (+)-PN200-110, diltiazem and (-)-desmethoxyverapamil to L-type Ca 2+ channel

By Shimasue K.   Urushidani T.   Hagiwara M.   Nagao T.  

European Journal of Pharmacology, Vol. 296, Iss. 3, 1996-02 ,pp. : 347-350

Elsevier

Access to resources Recommend Favorite

The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease

By  

Current Medicinal Chemistry, Vol. 16, Iss. 26, 2009-09 ,pp. : 3341-3358

Bentham Science Publishers

Access to resources Recommend Favorite